Acorah Software Products - Accounts Production 19.2.350 false true false true No description of principal activity 28 January 2025 31 January 2026 31 January 2026 16212358 Dr Mohsin MUKHTAR iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16212358 2025-01-27 16212358 2026-01-31 16212358 2025-01-28 2026-01-31 16212358 frs-core:CurrentFinancialInstruments 2026-01-31 16212358 frs-bus:PrivateLimitedCompanyLtd 2025-01-28 2026-01-31 16212358 frs-bus:FilletedAccounts 2025-01-28 2026-01-31 16212358 frs-bus:Micro-entities 2025-01-28 2026-01-31 16212358 frs-bus:AuditExempt-NoAccountantsReport 2025-01-28 2026-01-31 16212358 frs-bus:Director1 2025-01-28 2026-01-31
Registered number: 16212358
KAITOKE HEALTHCARE LIMITED
Unaudited Financial Statements
For The Year Ended 31 January 2026
ACTX Solutions Ltd
Balance Sheet
Registered number: 16212358
2026
£
Current assets 3,375
Creditors: Amounts Falling Due Within One Year (669 )
NET CURRENT ASSETS 2,706
TOTAL ASSETS LESS CURRENT LIABILITIES 2,706
Accruals and deferred income (350 )
NET ASSETS 2,356
CAPITAL AND RESERVES 2,356

Notes

1. General Information
KAITOKE HEALTHCARE LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 16212358 . The registered office is 16 Southwood Avenue, Knaphill, Woking, GU21 2EY.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Mohsin MUKHTAR
Director
08/02/2026